KKB Attorney Samantha Hong will be speaking at the ACI 12th (Virtual) Summit on Biosimilars and Innovator Biologics on June 22, 2021. Samantha will interview the FDA Keynote Speaker, Jessica … more
KKB Partner KS Reagan will be presenting at the Food and Drug Law Institute (FDLI)’s Introduction to Medical Device Law and Regulation course on … more
KKB Partner Will Woodlee will speak on June 8, 2021, at 3:45 pm ET during the American Conference Institute’s (ACI’s) virtual 9th Annual Legal, … more
KKB Partner Suzan Onel will be speaking at American University Washington College of Law’s Health Law and Policy Summer Speaker Series on … more
The Food and Drug Law Institute (FDLI) recently published the latest annual installment of its popular “top cases” publication, Top Food and Drug … more
By: KS Reagan, Peter Mathers, and Samantha Hong On May 27, 2021, HHS emphatically and unequivocally withdrew the agency’s November 2020 notice … more
By: Jacqueline J. Chan and Samantha Hong Like all entities faced with navigating the challenges of resuming operations as the COVID-19 pandemic … more
By: T. Daniel Logan and Jacqueline J. Chan Since 1973, the Federal Trade Commission (“the Commission”) has had the authority, under Section … more
KKB Partner Stacy Ehrlich will be moderating the panel, “A Paradigm Shift in Tobacco: Operating in the PMTA Post-Authorization Environment,” as part of the virtual … more
KKB Partner Suzan Onel will be moderating the panel, “FDA’s Breakthrough Devices Program and Safer Technologies Program (STeP): Strategies and Opportunities,” as … more
